Serum Anti-carbonic Anhydrase Antibodies and Oxidant–Antioxidant Balance in Patients with Acute Anterior Uveitis

References

• Barisani-Asenbauer T, Maca SM, Mejdoubi L, et al. Uveitis—a rare disease often associated with systemic diseases and infections: a systematic review of 2619 patients. Orphanet J Rare Dis. 2012 Aug 29;7:57
   PubMed Web of Science ®Google Scholar
• Cantarini L, Simonini G, Frediani B, et al. Treatment strategies for childhood noninfectious chronic uveitis: an update. Expert Opin Invest Drugs. 2012;21:1–6
   PubMed Web of Science ®Google Scholar
• Wendling D. Uveitis in seronegative arthritis. Curr Rheumatol Rep. 2012;14:402–408
   PubMed Web of Science ®Google Scholar
• Chang JH, McCluskey PJ, Wakefield D. Recent advances in Toll-like receptors and anterior uveitis. Clin Exp Ophthalmol. 2012;40:821–828
   PubMed Web of Science ®Google Scholar
• Chang JH, Wakefield D. Uveitis: a global perspective. Ocul Immunol Inflamm. 2002;10:263–279
   PubMed Web of Science ®Google Scholar
• Wakefield D, Gray P, Chang J, et al. The role of PAMPs and DAMPs in the pathogenesis of acute and recurrent anterior uveitis. Br J Ophthalmol. 2010;94:271–274
   PubMedGoogle Scholar
• Jha P, Sohn JH, Xu Q, et al. The complement system plays a critical role in the development of experimental autoimmune anterior uveitis. Invest Ophthalmol Vis Sci. 2006;47:1030–1038
   PubMedGoogle Scholar
• Du L, Kijlstra A, Yang P. Immune response genes in uveitis. Ocul Immunol Inflamm. 2009;17:249–256
   PubMed Web of Science ®Google Scholar
• Maldini C, Lavalley MP, Cheminant M, et al. Relationships of HLA-B51 or B5 genotype with Behcet's disease clinical characteristics: systematic review and meta-analyses of observational studies. Rheumatology (Oxford). 2012;51:887–900
   PubMed Web of Science ®Google Scholar
• Gul A, Ohno S. HLA-B*51 and Behçet disease. Ocul Immunol Inflamm. 2012;20:37–43
   PubMed Web of Science ®Google Scholar
• Yang MM, Lai TY, Tam PO, et al. CFH 184G as a genetic risk marker for anterior uveitis in Chinese females. Mol Vis. 2011;17:2655–2664
   PubMed Web of Science ®Google Scholar
• Chang JH, McCluskey PJ, Wakefield D. Acute anterior uveitis and HLA-B27. Surv Ophthalmol. 2005;50:364–388
   PubMed Web of Science ®Google Scholar
• Yeo TK, Ahad MA, Kuo NW, et al. Chemokine gene polymorphisms in idiopathic anterior uveitis. Cytokine. 2006;35:29–35
   PubMedGoogle Scholar
• Atan D, Heissigerova J, Kuffová L, et al. Tumor necrosis factor polymorphisms associated with tumor necrosis factor production influence the risk of idiopathic intermediate uveitis. Mol Vis. 2013;19:184–195
   PubMed Web of Science ®Google Scholar
• Ozdamar Y, Berker N, Bahar G, et al. Inflammatory mediators and posterior segment involvement in ocular Behcet disease. Eur J Ophthalmol. 2009;19:998–1003
   PubMed Web of Science ®Google Scholar
• Lan C, Tam PO, Chiang SW, et al. Manganese superoxide dismutase and chemokine genes polymorphisms in chinese patients with anterior uveitis. Invest Ophthalmol Vis Sci. 2009;50:5596–5600
   PubMed Web of Science ®Google Scholar
• Imtaiyaz Hassan M, Shajee B, Waheed A, et al. Structure, function and applications of carbonic anhydrase isozymes. Bioorg Med Chem. 2013;21:1570–1582
   PubMed Web of Science ®Google Scholar
• Aliyazicioglu R, Guven S, Mentese A, et al. Serum anti-carbonic anhydrase II antibodies and oxidant-antioxidant balance in pre-eclampsia. Am J Reprod Immunol. 2011;66:297–303
   PubMedGoogle Scholar
• Supuran CT, Scozzafava A. Carbonic anhydrases as targets for medicinal chemistry. Bioorg Med Chem. 2007;15:4336–4350
   PubMed Web of Science ®Google Scholar
• Tojo A, Miyashita K, Kinugasa S, et al. Acute tubulointerstitial nephritis with an autoantibody response against carbonic anhydrase II. Am J Med Sci. 2013;345:407–408
   PubMedGoogle Scholar
• Alver A, Senturk A, Cakirbay H, et al. Carbonic anhydrase II autoantibody and oxidative stress in rheumatoid arthritis. Clin Biochem. 2011;44:1385–1389
   PubMed Web of Science ®Google Scholar
• Sánchez-Castañón M, de las Heras-Castaño G, López-Hoyos M. Autoimmune pancreatitis: an underdiagnosed autoimmune disease with clinical, imaging and serological features. Autoimmun Rev. 2010;9:237–240
   PubMedGoogle Scholar
• Alver A, Menteşe A, Karahan SC, et al. Increased serum anti-carbonic anhydrase II antibodies in patients with Graves' disease. Exp Clin Endocrinol Diabetes. 2007;115:287–291
   PubMed Web of Science ®Google Scholar
• Erel O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem. 2004;37:112–119
   PubMed Web of Science ®Google Scholar
• Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem. 2005;38:1103–1111
   PubMed Web of Science ®Google Scholar
• Aycicek A, Erel O, Kocyigit A. Decreased total antioxidant capacity and increased oxidative stress in passive smoker infants and their mothers. Pediatr Int. 2005;47:635–639
   PubMed Web of Science ®Google Scholar
• Yagi K. Lipid peroxides and related radicals in clinical medicine. In Armstrong D (ed.), Free Radicals in Diagnostic Medicine. New York: Plenum Press; 1994:1–15
   Google Scholar
• Mentese A, Guven S, Sumer A, et al. Serum anti-carbonic anhydrase I and II antibodies and polycystic ovary syndrome. Turk J Biochem. 2013;38:9–13
   Google Scholar
• Alessandri C, Bombardieri M, Scrivo R, et al. Anti-carbonic anhydrase II antibodies in systemic sclerosis: association with lung involvement. Autoimmunity. 2003;36:85–89
   PubMed Web of Science ®Google Scholar
• Andoh A, Fujiyama Y, Yoshioka U, et al. Elevated serum anti-carbonic anhydrase II antibodies in patients with ulcerative colitis. Int J Mol Med. 2002;9:499–502
   PubMedGoogle Scholar
• Karahan SC, Guven S, Mentese A, et al. Serum anti-carbonic anhydrase I and II antibodies and idiopathic recurrent pregnancy loss. Reprod Biomed Online. 2009;19:859–863
   PubMedGoogle Scholar
• Inagaki Y, Jinno-Yoshida Y, Hamasaki Y, et al. A novel autoantibody reactive with carbonic anhydrase in sera from patients with systemic lupus erythematosus and Sjögren's syndrome. J Dermatol Sci. 1991;2:147–154
   PubMedGoogle Scholar
• Bosch-Morell F, Romá J, Marín N, et al. Role of oxygen and nitrogen species in experimental uveitis: anti-inflammatory activity of the synthetic antioxidant ebselen. Free Radic Biol Med. 2002;33:669–675
   PubMedGoogle Scholar
• Ishimoto S, Wu GS, Hayashi S, et al. Free radical tissue damages in the anterior segment of the eye in experimental autoimmune uveitis. Invest Ophthalmol Vis Sci. 1996;37:630–636
   PubMed Web of Science ®Google Scholar
• Taysi S, Demircan B, Akdeniz N, et al. Oxidant/antioxidant status in men with Behçet's disease. Clin Rheumatol. 2007;26:418–422
   PubMed Web of Science ®Google Scholar
• Turk A, Nuhoglu I, Mentese A, et al. The relationship between diabetic retinopathy and serum levels of ischemia-modified albumin and malondialdehyde. Retina. 2011;31:602–608
   PubMed Web of Science ®Google Scholar
• Satici A, Guzey M, Gurler B, et al. Malondialdehyde and antioxidant enzyme levels in the aqueous humor of rabbits in endotoxin-induced uveitis. Eur J Ophthalmol. 2003;13:779–783
   PubMed Web of Science ®Google Scholar
• Ahsan H, Ali A, Ali R. Oxygen free radicals and systemic autoimmunity. Clin Exp Immunol. 2003;131:398–404
   PubMed Web of Science ®Google Scholar
• Najim RA, Sharquie KE, Abu-Raghif AR. Oxidative stress in patients with Behcet's disease, I: correlation with severity and clinical parameters. J Dermatol. 2007;34:308–314
   PubMed Web of Science ®Google Scholar
• Schraufstätter I, Hyslop PA, Jackson JH, et al. Oxidant-induced DNA damage of target cells. J Clin Invest. 1988;82:1040–1050
   PubMed Web of Science ®Google Scholar